Terms: = Kidney tumors AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616 AND Prognosis
8 results:
1. [Cytopathological characteristics of smarca4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
2. Tazemetostat in the therapy of pediatric INI1-negative malignant rhabdoid tumors.
Vejmelkova K; Pokorna P; Noskova K; Faustmannova A; Drabova K; Pavelka Z; Bajciova V; Broz M; Tinka P; Jezova M; Palova H; Kren L; Valik D; Slaby O; Sterba J
Sci Rep; 2023 Dec; 13(1):21623. PubMed ID: 38062114
[TBL] [Abstract] [Full Text] [Related]
3. YAP-Activated SATB2 Is a Coactivator of NRF2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell Carcinoma.
Jin J; Chen F; He W; Zhao L; Lin B; Zheng D; Chen L; He H; He Q
Cancer Res; 2023 Mar; 83(5):786-803. PubMed ID: 36598364
[TBL] [Abstract] [Full Text] [Related]
4. The SWI/SNF chromatin-remodeling complex status in renal cell carcinomas with sarcomatoid or rhabdoid features.
Kinoshita F; Kohashi K; Sugimoto M; Takamatsu D; Kiyozawa D; Eto M; Oda Y
Virchows Arch; 2020 Nov; 477(5):651-660. PubMed ID: 32447490
[TBL] [Abstract] [Full Text] [Related]
5. High expression of smarca4 or SMARCA2 is frequently associated with an opposite prognosis in cancer.
Guerrero-MartÃnez JA; Reyes JC
Sci Rep; 2018 Feb; 8(1):2043. PubMed ID: 29391527
[TBL] [Abstract] [Full Text] [Related]
6. Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinoma.
Jiang W; Dulaimi E; Devarajan K; Parsons T; Wang Q; O'Neill R; Solomides C; Peiper SC; Testa JR; Uzzo R; Yang H
Oncotarget; 2017 Jun; 8(23):37423-37434. PubMed ID: 28445125
[TBL] [Abstract] [Full Text] [Related]
7. Coexistent loss of INI1 and brg1 expression in a rhabdoid renal cell carcinoma (RCC): implications for a possible role of SWI/SNF complex in the pathogenesis of RCC.
Rao Q; Xia QY; Shen Q; Shi SS; Tu P; Shi QL; Zhou XJ
Int J Clin Exp Pathol; 2014; 7(4):1782-7. PubMed ID: 24817979
[TBL] [Abstract] [Full Text] [Related]
8. Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors.
DeCristofaro MF; Betz BL; Wang W; Weissman BE
Oncogene; 1999 Dec; 18(52):7559-65. PubMed ID: 10602515
[TBL] [Abstract] [Full Text] [Related]
